Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT04427943
Active, not recruiting Observational

Outcome After Revisions of Infected Knee Arthroplasties

NCT04427943 · tracked via the Priya Life Science Denmark tracker
Sponsor
Odense University Hospital
Phase
Observational
Started
2020-01-01
Last updated
2024-12-11

Condition(s) studied

Periprosthetic Knee Infection

Investigational drug(s) / intervention(s)

revision surgery

revision surgery: The intervention is the planned revision surgery according to local guidelines.

Study summary

A prospective multicenter cohort study on all types of revision knee arthroplasty procedures performed due to infection.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Clinical signs of periprosthetic knee joint infection and indication for revision surgery * Speak and understand Danish and have given informed consent Exclusion Criteria: * Participation in "one-stage versus two-stage revisions of the infected knee arthroplasty"

Primary outcome measure(s)

  • Change in Oxford Knee Score (Area Under Curve (AUC) from preoperatively to 12 months postoperatively) — Measured preoperatively 6 weeks, 3, 6, 9, 12 months postoperatively
    Change in Oxford Knee Score from preoperatively to 12 months postoperatively measured as Area Under Curve. Oxford Knee Score ranges from 0 to 48, 48 = best score.

Trial sites (8)

FacilityCityRegionStatus
Aalborg University Hospital Aalborg Denmark
Bispebjerg Hospital Copenhagen Denmark
Hvidovre Copenhagen Denmark
Rigshospitalet Copenhagen Denmark
Horsens Hospital Horsens Denmark
Næstved Hospital Næstved Denmark
Odense Universitets Hospital Odense Denmark
Vejle Hospital Vejle Denmark

More Odense University Hospital trials in Denmark

Ultrasound Applicability in the Assessment of Patients With Fibrosing Interstitial Lung Disease Enrolling by invitation
Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring Recruiting
Immunotherapy in Patients With Early dMMR Rectal Cancer Recruiting
Permissive Hyperthermia in Acute Brain Injury Active, not recruiting
Vitamin D and Angiogenic Markers in Odense Child Cohort 1 Active, not recruiting

Other trials for the same condition

One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04427943 on ClinicalTrials.gov ↗ ← All trials in Denmark